In today’s Pharmaceutical Executive Daily, a new a is expected to evolve in 2026, the FDA rejects AstraZeneca’s application ...
The global demand on agri-food systems continues to grow, necessitating innovative strategies for increasing agricultural ...
1hon MSN
Scientists use RNA nanotechnology to program living cells, opening a new path for cancer cure
Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results